Covering detection through treatment decision and surveillance

At ASCO18, Philips will spotlight specific, end-to-end oncology solutions to empower data-driven clinical decision support driving clinical, operational and financial benefits across the following key areas:


Integrative Diagnostics:

· IntelliSpace Genomics, a cloud-based precision medicine platform, automates genomic analysis for more precise diagnostics to inform therapy options and clinical trials. The solution also provides automated end-to-end workflows and customizable knowledgebase and report generation, while also improving data safety and security.

· IntelliSpace Portal, an advanced visualization tool, supports the clinical workflow across the cancer care continuum, including the ability to assess lung nodules over time with the CT Lung Nodule Assessment, monitor tumor progression and treatment response with Multimodality Tumor Tracking, and prepare for complex oncology procedures with 3D modeling.

· IntelliSite Pathology, the first and currently only digital pathology solution in the U.S. to be marketed for primary diagnostic use, can aid pathologists to view and diagnose digital images of surgical pathology slides to streamline workflow and extend collaboration with the aim of increasing diagnostic confidence.

Deeper Insights:

· IntelliSpace Oncology assists with complex treatment decisions, including hundreds of FDA-approved anti-cancer agents, and provides daily patient care insights based on evidence-based decision tools to promote guidelines adherence.

· OncoSignal, a proprietary test system unique to Philips, measures signaling pathway activity in individual tumor samples to predict targeted therapy response. Test results could help to select the best systemic treatment, allowing for simplified testing, better stratification and new therapy options [2].

Confident path:

· The Dana-Farber Clinical Pathways will be deployed through the Philips IntelliSpace Oncology Platform, providing clinical decision support to physicians via a patient-centric solution. The implementation will help oncologists quickly reach the most appropriate cancer treatments for patients, based on the unified view of the patient across diagnostic modalities and the embedded knowledge of Clinical Pathways, and can be delivered through existing EHR platforms.

· To drive efficient and personalized patient specific radiotherapy treatment planning workflows, Philips has integrated Sun Nuclear’s PlanIQ technology into Pinnacle to create Pinnacle Auto-Planning with PlanIQ. This allows for better management of risk with automated, template driven planning workflows that can also assist in MACRA and ACR accreditation initiatives and drive continuous quality improvement with benchmarking tools.

Rad Oncology Homepage